IDYA is trading 4.4% up today at $36.44 as the stock rebounds from selling pressure tied to its recently priced $300 million stock and warrant offering.
- Shares are recovering after an initial 7–8% decline triggered by dilution concerns when the equity raise was first announced and priced at a discount.
- Investors are now shifting focus toward the company’s expanded cash runway and its enhanced capacity to fund its clinical pipeline following the capital injection.